Calidi Biotherapeutics (CLDI) Q1 2025 Annual Earnings
CLDI·Reported May 14, 2025·Before market open
Diluted EPS came in at $-2.16 (+91.2% YoY), missed the $-0.15 consensus by $2.01.
Diluted EPS
$-2.16missed by $2.01
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Calidi Biotherapeutics's Q1 2025 earnings report.
Calidi Biotherapeutics (CLDI) reported Q1 2025 earnings on May 14, 2025 before market open.
Calidi Biotherapeutics reported diluted EPS of $-2.16 for Q1 2025.
EPS missed the consensus estimate of $-0.15 by $2.01.
Compared to the same quarter a year prior, diluted EPS grew 91.2% from $-24.48.
You can read the 10-K periodic report (0001641172-25-001810) directly on SEC EDGAR. The filing index links above go to sec.gov.